China Epigenetics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors supporting market growth.

    Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Epigenetics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Epigenetics market. Detailed analysis of key players, along with key growth strategies adopted by Epigenetics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Illumina

    • Merck & Co Ltd

    • Merck Millipore

    • Zymo Research Corporation

    • Active Motif

    • Bio-Rad

    • New England Biolabs

    • Agilent

    • Sigma-Aldrich Corporation

    • Zymo Research

    • Perkinelmer

    • Novartis AG

    By Type:

    • DNA Methylation

    • Histone Modifications

    • Other Technologies

    By End-User:

    • Oncology

    • Metabolic Diseases

    • Developmental Biology

    • Immunology

    • Cardiovascular Diseases

    • Other Applications

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Epigenetics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Epigenetics Market Size and Growth Rate of DNA Methylation from 2016 to 2027

    • 1.3.2 China Epigenetics Market Size and Growth Rate of Histone Modifications from 2016 to 2027

    • 1.3.3 China Epigenetics Market Size and Growth Rate of Other Technologies from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Epigenetics Market Size and Growth Rate of Oncology from 2016 to 2027

    • 1.4.2 China Epigenetics Market Size and Growth Rate of Metabolic Diseases from 2016 to 2027

    • 1.4.3 China Epigenetics Market Size and Growth Rate of Developmental Biology from 2016 to 2027

    • 1.4.4 China Epigenetics Market Size and Growth Rate of Immunology from 2016 to 2027

    • 1.4.5 China Epigenetics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • 1.4.6 China Epigenetics Market Size and Growth Rate of Other Applications from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Epigenetics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Epigenetics by Major Types

    • 3.4.1 Market Size and Growth Rate of DNA Methylation

    • 3.4.2 Market Size and Growth Rate of Histone Modifications

    • 3.4.3 Market Size and Growth Rate of Other Technologies

    4 Segmentation of Epigenetics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Epigenetics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Epigenetics in Oncology

    • 4.4.2 Market Size and Growth Rate of Epigenetics in Metabolic Diseases

    • 4.4.3 Market Size and Growth Rate of Epigenetics in Developmental Biology

    • 4.4.4 Market Size and Growth Rate of Epigenetics in Immunology

    • 4.4.5 Market Size and Growth Rate of Epigenetics in Cardiovascular Diseases

    • 4.4.6 Market Size and Growth Rate of Epigenetics in Other Applications

    5 Market Analysis by Regions

    • 5.1 China Epigenetics Production Analysis by Regions

    • 5.2 China Epigenetics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Epigenetics Landscape Analysis

    • 6.1 North China Epigenetics Landscape Analysis by Major Types

    • 6.2 North China Epigenetics Landscape Analysis by Major End-Users

    7 Central China Epigenetics Landscape Analysis

    • 7.1 Central China Epigenetics Landscape Analysis by Major Types

    • 7.2 Central China Epigenetics Landscape Analysis by Major End-Users

    8 South China Epigenetics Landscape Analysis

    • 8.1 South China Epigenetics Landscape Analysis by Major Types

    • 8.2 South China Epigenetics Landscape Analysis by Major End-Users

    9 East China Epigenetics Landscape Analysis

    • 9.1 East China Epigenetics Landscape Analysis by Major Types

    • 9.2 East China Epigenetics Landscape Analysis by Major End-Users

    10 Northeast China Epigenetics Landscape Analysis

    • 10.1 Northeast China Epigenetics Landscape Analysis by Major Types

    • 10.2 Northeast China Epigenetics Landscape Analysis by Major End-Users

    11 Southwest China Epigenetics Landscape Analysis

    • 11.1 Southwest China Epigenetics Landscape Analysis by Major Types

    • 11.2 Southwest China Epigenetics Landscape Analysis by Major End-Users

    12 Northwest China Epigenetics Landscape Analysis

    • 12.1 Northwest China Epigenetics Landscape Analysis by Major Types

    • 12.2 Northwest China Epigenetics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Illumina

      • 13.1.1 Illumina Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck & Co Ltd

      • 13.2.1 Merck & Co Ltd Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Merck Millipore

      • 13.3.1 Merck Millipore Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Zymo Research Corporation

      • 13.4.1 Zymo Research Corporation Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Active Motif

      • 13.5.1 Active Motif Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Bio-Rad

      • 13.6.1 Bio-Rad Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 New England Biolabs

      • 13.7.1 New England Biolabs Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Agilent

      • 13.8.1 Agilent Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sigma-Aldrich Corporation

      • 13.9.1 Sigma-Aldrich Corporation Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Zymo Research

      • 13.10.1 Zymo Research Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Perkinelmer

      • 13.11.1 Perkinelmer Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Novartis AG

      • 13.12.1 Novartis AG Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Epigenetics Market Size and Growth Rate of DNA Methylation from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Histone Modifications from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Other Technologies from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Epigenetics Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Metabolic Diseases from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Developmental Biology from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Immunology from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure China Epigenetics Market Size and Growth Rate of Other Applications from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Epigenetics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Epigenetics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Epigenetics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Epigenetics by Different Types from 2016 to 2027

    • Table Consumption Share of Epigenetics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of DNA Methylation

    • Figure Market Size and Growth Rate of Histone Modifications

    • Figure Market Size and Growth Rate of Other Technologies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Epigenetics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Epigenetics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Metabolic Diseases

    • Figure Market Size and Growth Rate of Developmental Biology

    • Figure Market Size and Growth Rate of Immunology

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Other Applications

    • Table China Epigenetics Production by Regions

    • Table China Epigenetics Production Share by Regions

    • Figure China Epigenetics Production Share by Regions in 2016

    • Figure China Epigenetics Production Share by Regions in 2021

    • Figure China Epigenetics Production Share by Regions in 2027

    • Table China Epigenetics Consumption by Regions

    • Table China Epigenetics Consumption Share by Regions

    • Figure China Epigenetics Consumption Share by Regions in 2016

    • Figure China Epigenetics Consumption Share by Regions in 2021

    • Figure China Epigenetics Consumption Share by Regions in 2027

    • Table North China Epigenetics Consumption by Types from 2016 to 2027

    • Table North China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure North China Epigenetics Consumption Share by Types in 2016

    • Figure North China Epigenetics Consumption Share by Types in 2021

    • Figure North China Epigenetics Consumption Share by Types in 2027

    • Table North China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table North China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Epigenetics Consumption Share by End-Users in 2016

    • Figure North China Epigenetics Consumption Share by End-Users in 2021

    • Figure North China Epigenetics Consumption Share by End-Users in 2027

    • Table Central China Epigenetics Consumption by Types from 2016 to 2027

    • Table Central China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure Central China Epigenetics Consumption Share by Types in 2016

    • Figure Central China Epigenetics Consumption Share by Types in 2021

    • Figure Central China Epigenetics Consumption Share by Types in 2027

    • Table Central China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table Central China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Epigenetics Consumption Share by End-Users in 2016

    • Figure Central China Epigenetics Consumption Share by End-Users in 2021

    • Figure Central China Epigenetics Consumption Share by End-Users in 2027

    • Table South China Epigenetics Consumption by Types from 2016 to 2027

    • Table South China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure South China Epigenetics Consumption Share by Types in 2016

    • Figure South China Epigenetics Consumption Share by Types in 2021

    • Figure South China Epigenetics Consumption Share by Types in 2027

    • Table South China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table South China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Epigenetics Consumption Share by End-Users in 2016

    • Figure South China Epigenetics Consumption Share by End-Users in 2021

    • Figure South China Epigenetics Consumption Share by End-Users in 2027

    • Table East China Epigenetics Consumption by Types from 2016 to 2027

    • Table East China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure East China Epigenetics Consumption Share by Types in 2016

    • Figure East China Epigenetics Consumption Share by Types in 2021

    • Figure East China Epigenetics Consumption Share by Types in 2027

    • Table East China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table East China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Epigenetics Consumption Share by End-Users in 2016

    • Figure East China Epigenetics Consumption Share by End-Users in 2021

    • Figure East China Epigenetics Consumption Share by End-Users in 2027

    • Table Northeast China Epigenetics Consumption by Types from 2016 to 2027

    • Table Northeast China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Epigenetics Consumption Share by Types in 2016

    • Figure Northeast China Epigenetics Consumption Share by Types in 2021

    • Figure Northeast China Epigenetics Consumption Share by Types in 2027

    • Table Northeast China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Epigenetics Consumption Share by End-Users in 2016

    • Figure Northeast China Epigenetics Consumption Share by End-Users in 2021

    • Figure Northeast China Epigenetics Consumption Share by End-Users in 2027

    • Table Southwest China Epigenetics Consumption by Types from 2016 to 2027

    • Table Southwest China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Epigenetics Consumption Share by Types in 2016

    • Figure Southwest China Epigenetics Consumption Share by Types in 2021

    • Figure Southwest China Epigenetics Consumption Share by Types in 2027

    • Table Southwest China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Epigenetics Consumption Share by End-Users in 2016

    • Figure Southwest China Epigenetics Consumption Share by End-Users in 2021

    • Figure Southwest China Epigenetics Consumption Share by End-Users in 2027

    • Table Northwest China Epigenetics Consumption by Types from 2016 to 2027

    • Table Northwest China Epigenetics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Epigenetics Consumption Share by Types in 2016

    • Figure Northwest China Epigenetics Consumption Share by Types in 2021

    • Figure Northwest China Epigenetics Consumption Share by Types in 2027

    • Table Northwest China Epigenetics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Epigenetics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Epigenetics Consumption Share by End-Users in 2016

    • Figure Northwest China Epigenetics Consumption Share by End-Users in 2021

    • Figure Northwest China Epigenetics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of Merck & Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Ltd

    • Figure Sales and Growth Rate Analysis of Merck & Co Ltd

    • Figure Revenue and Market Share Analysis of Merck & Co Ltd

    • Table Product and Service Introduction of Merck & Co Ltd

    • Table Company Profile and Development Status of Merck Millipore

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Millipore

    • Figure Sales and Growth Rate Analysis of Merck Millipore

    • Figure Revenue and Market Share Analysis of Merck Millipore

    • Table Product and Service Introduction of Merck Millipore

    • Table Company Profile and Development Status of Zymo Research Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zymo Research Corporation

    • Figure Sales and Growth Rate Analysis of Zymo Research Corporation

    • Figure Revenue and Market Share Analysis of Zymo Research Corporation

    • Table Product and Service Introduction of Zymo Research Corporation

    • Table Company Profile and Development Status of Active Motif

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Active Motif

    • Figure Sales and Growth Rate Analysis of Active Motif

    • Figure Revenue and Market Share Analysis of Active Motif

    • Table Product and Service Introduction of Active Motif

    • Table Company Profile and Development Status of Bio-Rad

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad

    • Figure Sales and Growth Rate Analysis of Bio-Rad

    • Figure Revenue and Market Share Analysis of Bio-Rad

    • Table Product and Service Introduction of Bio-Rad

    • Table Company Profile and Development Status of New England Biolabs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of New England Biolabs

    • Figure Sales and Growth Rate Analysis of New England Biolabs

    • Figure Revenue and Market Share Analysis of New England Biolabs

    • Table Product and Service Introduction of New England Biolabs

    • Table Company Profile and Development Status of Agilent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent

    • Figure Sales and Growth Rate Analysis of Agilent

    • Figure Revenue and Market Share Analysis of Agilent

    • Table Product and Service Introduction of Agilent

    • Table Company Profile and Development Status of Sigma-Aldrich Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sigma-Aldrich Corporation

    • Figure Sales and Growth Rate Analysis of Sigma-Aldrich Corporation

    • Figure Revenue and Market Share Analysis of Sigma-Aldrich Corporation

    • Table Product and Service Introduction of Sigma-Aldrich Corporation

    • Table Company Profile and Development Status of Zymo Research

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zymo Research

    • Figure Sales and Growth Rate Analysis of Zymo Research

    • Figure Revenue and Market Share Analysis of Zymo Research

    • Table Product and Service Introduction of Zymo Research

    • Table Company Profile and Development Status of Perkinelmer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perkinelmer

    • Figure Sales and Growth Rate Analysis of Perkinelmer

    • Figure Revenue and Market Share Analysis of Perkinelmer

    • Table Product and Service Introduction of Perkinelmer

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.